Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 550 of 1,261
  1. US 10045943

    Implantable medical devices for extended release of therapeutic agents

    Nano Precision Medical, Inc. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  2. US 10045990

    ERBB4 inhibitors and methods of use thereof

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  3. US 10047401

    Expression protein-coding and noncoding genes as prognostic classifiers in early stage lung cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  4. US 10047396

    Biomarkers for diagnosis of transient ischemic attacks

    The Regents of the University of California · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  5. US 10047361

    Disulfide-containing alkyne linking agents

    Arrowhead Pharmaceuticals, Inc. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  6. US 10046016

    Mutant adeno-associated virus virions and methods of use thereof

    The Regents of the University of California · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  7. US 10047330

    Alcoholic compositions having a lowered risk of acetaldehydemia

    Deuterla Beverages, LLC · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  8. US 10047160

    Anti-EGFRvIII antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  9. US 10047148

    Neutralizing GP41 antibodies and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  10. US 10047147

    Neutralizing GP41 antibodies and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  11. US 10047125

    Peptide having activity to improve skin condition and use thereof

    CAREGEN CO., LTD. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  12. US 10047153

    Human antibodies to Fel d1 and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  13. US 10047104

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Aurigene Discovery Technologies Limited · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  14. US 10047095

    sGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  15. US 10047028

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  16. US 10039741

    Use of delta tocopherol for the treatment of lysosomal storage disorders

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  17. US 10039737

    Multi-arm polymeric alkanoate conjugates

    Nektar Therapeutics · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  18. US 10039725

    Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene

    The Regents of the University of California · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  19. US 10039729

    Use of kukoamine A and kukoamine B

    The First Affiliated Hospital, Third Military Medical University, PLA · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  20. US 10041053

    Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

    Precision BioSciences, Inc. · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  21. US 10040799

    Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity

    Northwestern University · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  22. US 10040826

    Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens

    The United States of America as represented by the Secretary of the Army · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  23. US 10040830

    Methods and compositions for protein delivery

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  24. US 10040858

    Anti-CSF1R antibodies for treating PVNS

    Five Prime Therapeutics, Inc. · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.